Case File
efta-01761212DOJ Data Set 10OtherEFTA01761212
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01761212
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Fenn, Patrick
Sent:
Monday, May 20, 2013 1:08 PM
To:
[email protected]*
Subject:
Re: FW: Early Termination Calculation
Ok. Yes, thinking through possibilities.
From: Jeffrey Epstein Imailto:[email protected]
Sent: Monday, May 20, 2013 08:19 AM
To: Fenn, Patrick
Subject: Re: FW: Early Termination Calculation
could they run the calcuations at a 30 and 35 dollar price for apo , thanks, also have you given tought to refreshing the
basis in amh.? new loan,? partnership, guaranteed either payments or assignment of train whole?
On Mon, May 20, 2013 at 7:46 AM, Fenn, Patric
> wrote:
Jeffrey,
Calculation from Brian Knudson at E&Y. Note that this relates only to the unexchanged units, and does not
include the existing TRA payments.
Regards
Hi Patrick,
Attached is the calculation that we put together for Leon. As we discussed, this only calculates the estimated
early termination payment with respect to the APP units held by Leon - it does not yet calculate the estimated early
termination payment with respect to remaining TRA benefits related to the 2007 exchange. I have added an
assumptions tab to the workbook outlining many of the items that we discussed. Thanks,
EFTA_R1_00065901
EFTA01761212
Brian
Brian Knudson I Partner I National Tax - Partnership and Joint Ventures
Ernst & Young LLP
200 South Sixth Street, Suite 1400, Minneapolis, Minnesota 55402, United States of America
Website: www.ey.com <http://www.ey.com>
Assistant: Lenora Wold I Phone:
Thank you for considering the environmental impact of printing emails.
Any U.S. tax advice contained in the body of this e-mail was not intended or written to be used, and cannot be
used, by the recipient for the purpose of avoiding penalties that may be imposed under the Internal Revenue Code or
applicable state or local tax law provisions.
The information contained in this message may be privileged and confidential and protected from disclosure. If
the reader of this message is not the intended recipient, or an employee or agent responsible for delivering this message
to the intended recipient, you are hereby notified that any dissemination, distribution or copying of this communication
is strictly prohibited. If you have received this communication in error, please notify us immediately by replying to the
message and deleting it from your computer.
Notice required by law: This e-mail may constitute an advertisement or solicitation under U.S. law, if its primary
purpose is to advertise or promote a commercial product or service. You may choose not to receive advertising and
promotional messages from Ernst & Young LLP (except for Ernst & Young Online and the ey.com <http://ey.com>
website, which track e-mail preferences through a separate process) at this e-mail address by forwarding this message
to [email protected] <mailto:[email protected]> . If you do so, the sender of this message will be notified
promptly. Our principal postal address is S Times Square, New York, NY 10036. Thank you. Ernst & Young LLP
IRS Circular 230 Notice Requirement: This communication is not given in the form of a covered opinion, within
the meaning of Circular 230 issued by the United States Secretary of the Treasury. Thus, we are required to inform you
that you cannot rely upon any tax advice contained in this communication for the purpose of avoiding United States
federal tax penalties. In addition, any tax advice contained in this communication may not be used to promote, market
or recommend a transaction to another party.
The information contained in this e-mail message is intended only for the personal and confidential use of the
recipient(s) named above. If you have received this communication in error, please notify us immediately by e-mail, and
delete the original message.
2
EFTA_R1_00065902
EFTA01761213
The information contained in this communication is confidential, may be attorney-client privileged, may constitute
inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized
use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you
have received this communication in error, please notify us immediately by return e-mail or by e-mail to
[email protected] <mailto:[email protected]> , and destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
IRS Circular 230 Notice Requirement: This communication is not given in the form of a covered opinion, within the
meaning of Circular 230 issued by the United States Secretary of the Treasury. Thus, we are required to inform you that
you cannot rely upon any tax advice contained in this communication for the purpose of avoiding United States federal
tax penalties. In addition, any tax advice contained in this communication may not be used to promote, market or
recommend a transaction to another party.
The information contained in this e-mail message is intended only for the personal and confidential use of the
recipient(s) named above. If you have received this communication in error, please notify us immediately by e-mail, and
delete the original message.
3
EFTA_R1_00065903
EFTA01761214
Technical Artifacts (6)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Email
[email protected]URL
http://ey.comURL
http://www.ey.comWire Ref
refreshingRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.